title: A medical cause for fifty shades of grey.
authors: Department of Medical Oncology, Daniel den Hoed Cancer Center, Erasmus MC, Rotterdam, the Netherlands.
authors: M
authors: M
authors: van der Graaf
authors: C
authors: C
authors: Seynaeve
authors: W
authors: W
authors: Kruit
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001365:Axilla; D001859:Bone Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008543:Melanins / Q000652:urine; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000556:secondary; D008548:Melanosis / Q000209:etiology*; D008875:Middle Aged; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D013449:Sulfonamides / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D008543:Melanins; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf